These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Pharmacoeconomic assessment of specific immunotherapy versus current symptomatic treatment for allergic rhinitis and asthma in France. Omnes LF; Bousquet J; Scheinmann P; Neukirch F; Jasso-Mosqueda G; Chicoye A; Champion L; Fadel R Eur Ann Allergy Clin Immunol; 2007 May; 39(5):148-56. PubMed ID: 17626329 [TBL] [Abstract][Full Text] [Related]
44. [Letter:Changes in IgE after dust desensitization]. Bruttmann G; Agnius-Delord C; Ruckebusch M Nouv Presse Med; 1976 Mar; 5(11):717. PubMed ID: 1264603 [No Abstract] [Full Text] [Related]
45. [Allergic rhinitis and asthma: pathophysiological relationship and implications for treatment]. Diamant Z; Tarasevych S; Chandoesing P; van Wijk RG; de Groot H Ned Tijdschr Geneeskd; 2006 Jan; 150(2):77-82. PubMed ID: 16440561 [TBL] [Abstract][Full Text] [Related]
49. Cost-effectiveness of specific immunotherapy with Grazax in allergic rhinitis co-existing with asthma. Nasser S; Vestenbaek U; Beriot-Mathiot A; Poulsen PB Allergy; 2008 Dec; 63(12):1624-9. PubMed ID: 19032235 [TBL] [Abstract][Full Text] [Related]
50. Safety of sublingual immunotherapy with a monomeric allergoid in very young children. Agostinis F; Tellarini L; Canonica GW; Falagiani P; Passalacqua G Allergy; 2005 Jan; 60(1):133. PubMed ID: 15575951 [No Abstract] [Full Text] [Related]
51. Study design of immunotherapy of ragweed allergy. Franklin W N Engl J Med; 1977 Mar; 296(10):573-4. PubMed ID: 618362 [No Abstract] [Full Text] [Related]
52. [Interest of allergology evaluation for the treatment of asthma and rhinosinusitis]. Michel O Rev Med Brux; 2008 Sep; 29(4):393-9. PubMed ID: 18949994 [TBL] [Abstract][Full Text] [Related]
53. [Immunotherapy of allergic diseases]. Chyrek-Borowska S Pol Arch Med Wewn; 1979 Aug; 62(2):117-21. PubMed ID: 503891 [No Abstract] [Full Text] [Related]
54. [The significance of infection for the allergic disorders of the respiratory tract. IV. The results of immunotherapy in patients with bronchial asthma and vasomotor rhinitis]. Zavázal V Allerg Asthma (Leipz); 1965; 11(6):278-85. PubMed ID: 5887935 [No Abstract] [Full Text] [Related]
55. The effects of allergen-specific immunotherapy on polymorphonuclear leukocyte functions in patients with seasonal allergic rhinitis. Soyoğul Gürer U; Büyüköztürk S; Palandüz S; Rayaman E; Colakoglu B; Cevikbaş A Int Immunopharmacol; 2005 Apr; 5(4):661-6. PubMed ID: 15710335 [TBL] [Abstract][Full Text] [Related]
56. [On hyposensitizing therapy in respiratory allergic syndromes caused by pollens and inhalant substances, with special reference to "Parietaria officinalis" and to house dusts]. Negrini AC Folia Allergol (Roma); 1970; 17(3):262-70. PubMed ID: 5517218 [No Abstract] [Full Text] [Related]